Miles International

Miles International, established in 2002, is a Mumbai-based pharmaceutical trading company specializing in the export and import of branded and generic medicines. The company has been supplying products to regions including Latin America, the Caribbean, Eastern Europe, and North Africa. Miles International is recognized for its commitment to quality, competitive pricing, and comprehensive services.

The company's product portfolio encompasses generic drugs, branded pharmaceuticals, and over-the-counter (OTC) health and beauty products. Miles International also offers specialized services such as cold chain management, drop shipments, and parallel imports. The firm's suppliers include prominent pharmaceutical manufacturers like Sun Pharma, Cipla, Alkem Laboratories, Natco, Naprod, Khandelwal Laboratories, and Serum Institute of India.

Miles International operates as a pharmaceutical trading company and does not own manufacturing facilities. Instead, it collaborates with established pharmaceutical manufacturers to source its products. The company emphasizes adherence to Good Distribution Practices (GDP) and Good Manufacturing Practices (GMP) to ensure product quality and safety.

The Managing Director of Miles International is Brajesh Sahaya, who has been instrumental in the company's growth and strategic direction. Under his leadership, the company has expanded its operations and product offerings, focusing on quality and customer satisfaction.

Miles International's export activities are primarily focused on regions such as Latin America, the Caribbean, Eastern Europe, and North Africa. The company has established a reputation for supplying quality medicines at competitive prices and has been supplying products to these regions since 2006. While specific regulatory approvals in the US, EU, UK, Australia, and Japan are not detailed in the available sources, the company's adherence to international standards suggests a commitment to meeting regulatory requirements in these markets.

Miles International has a significant presence in emerging markets, including Africa, Latin America, and Southeast Asia. The company's focus on supplying quality medicines to these regions aligns with the World Health Organization's prequalification program, which aims to ensure the quality, safety, and efficacy of medical products.

Miles International's geographic strategy involves focusing on regions such as Latin America, the Caribbean, Eastern Europe, and North Africa. This targeted approach allows the company to concentrate its resources and expertise, reducing concentration risk and enhancing its market presence in these areas.

As a pharmaceutical trading company, Miles International does not manufacture products but sources them from established pharmaceutical manufacturers. Therefore, the company does not have FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, or inspection history. However, the company emphasizes adherence to international standards, including Good Distribution Practices (GDP) and Good Manufacturing Practices (GMP), to ensure product quality and safety.

Miles International emphasizes adherence to international standards, including Good Distribution Practices (GDP) and Good Manufacturing Practices (GMP), to ensure product quality and safety. The company's suppliers are expected to comply with these standards, aligning with the World Health Organization's guidelines for the distribution and manufacturing of pharmaceutical products.

As a pharmaceutical trading company, Miles International sources products from various manufacturers. While specific details regarding the company's compliance with the Central Drugs Standard Control Organization (CDSCO) regulations, state drug controller approvals, and export No Objection Certificates (NOCs) are not provided in the available sources, the company's emphasis on adhering to international standards suggests a commitment to meeting regulatory requirements in India.

There are no specific records of Form 483 observations, warning letters, or import alerts associated with Miles International. The company emphasizes adherence to international standards, including Good Distribution Practices (GDP) and Good Manufacturing Practices (GMP), to ensure product quality and safety.

Miles International operates in a competitive landscape with several key players in the pharmaceutical trading industry. While specific market share comparisons are not available, the company's focus on quality, competitive pricing, and comprehensive services positions it as a strong competitor in its target markets.

Miles International's key differentiators include its commitment to quality, competitive pricing, and comprehensive services such as cold chain management, drop shipments, and parallel imports. The company's emphasis on adhering to international standards, including Good Distribution Practices (GDP) and Good Manufacturing Practices (GMP), further distinguishes it in the market.

Miles International's current strategic direction focuses on supplying quality medicines to regions such as Latin America, the Caribbean, Eastern Europe, and North Africa. The company's future outlook includes leveraging its widespread network of customers to proactively benefit from synergistic opportunities with global collaborators, aiming for continued growth and expansion in the pharmaceutical trading industry.

Miles International has established strong relationships with a diverse supplier base, including prominent pharmaceutical manufacturers like Sun Pharma, Cipla, Alkem Laboratories, Natco, Naprod, Khandelwal Laboratories, and Serum Institute of India. The company's emphasis on adhering to international standards, including Good Distribution Practices (GDP) and Good Manufacturing Practices (GMP), indicates a reliable and consistent track record in sourcing and supplying pharmaceutical products.

Importers should verify the following certifications when sourcing from Miles International:

• FDA Approval: To ensure compliance with U.S. regulatory standards.

• WHO-GMP Certification: To confirm adherence to the World Health Organization's Good Manufacturing Practices.

• EU GMP Certification: To verify compliance with European Union Good Manufacturing Practices.

• ISO Certification: To ensure quality management systems meet international standards.

These certifications can typically be verified through the respective regulatory bodies' official websites or by requesting documentation directly from Miles International.

When conducting due diligence on Miles International, consider the following steps:

• Verify Certifications: Ensure the company holds relevant certifications such as FDA approval, WHO-GMP, EU GMP, and ISO.

• Assess Supplier Relationships: Evaluate the company's partnerships with reputable pharmaceutical manufacturers.

• Review Compliance Records: Check for adherence to international standards like Good Distribution Practices (GDP) and Good Manufacturing Practices (GMP).

• Evaluate Financial Stability: Review financial statements and credit history to assess the company's financial health.

• Inspect Logistics Capabilities: Assess the company's ability to manage cold chain logistics and ensure timely deliveries.

Be cautious of red flags such as lack of transparency, inconsistent product quality, or non-compliance with regulatory standards. Recommended pre-order checks include verifying product certifications, assessing shipping and handling procedures, and confirming the company's reputation in the industry.